Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Learn which index funds have the lowest fees for retirement and how expense ratios impact your long-term returns. This guide highlights cost-conscious picks and practical tips.
27,216 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Harvey, an AI-driven legal tech startup, has surged to an $11 billion valuation after attracting OpenAI backing. The ...
Li Lu’s Himalaya Capital places a near alarmingly large bet on Alphabet, powering a dramatic year for the fund and re...
As Warren Buffett's successor, Greg Abel has begun steering Berkshire Hathaway's portfolio with careful turns. A nota...
A practical guide to Warner Music’s 2026 outlook for investors. Explore growth drivers, margins, and the risks that c...
Step into the 2026 beauty health (skin) investing landscape. This guide translates early 2026 earnings signals into a...
Plug Power's Q1 2026 earnings call offers a window into a fast-evolving hydrogen economy. This guide breaks down reve...
Nextpower is set to publish Q4 results amid a swift strategic shift to a solar infrastructure platform. A backlog abo...
Birkenstock's 2026 earnings reveal how the brand is balancing direct-to-consumer growth with wholesale pressures. Thi...
Carlson Investments just revealed a sizable Fastly stake, sparking questions about the stock’s future. This guide bre...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
When a chief financial officer sells a sizable stake, investors take notice. This article breaks down Shoals Technolo...